Bottom line
GTHRX vs SWHFX: the short answer
GTHRX (INVESCO Health Care Fund) and SWHFX (Schwab Health Care Fund) are both mutual funds.
SWHFX is cheaper at 0.8% vs 1.32% — a difference of $52 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +3.5% for GTHRX.
Updated Nov 19, 2026
GTHRX vs SWHFX side by side
| GTHRX | SWHFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.32% | 0.8% |
| Annual cost per $10k | $132 | $80 |
| 10-yr cost on $10k (prospectus) | $1,590 | $990 |
| Max front load | 0% | — |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +15.2% | +15.9% |
| 5-yr return (annualized) | +3.5% | +6.5% |
| 10-yr return (annualized) | +6.1% | +8.1% |
| Best quarter | +19.6% | +15.3% |
| Worst quarter | −16.5% | −12.1% |
| Net assets (fund) | $1.2B | $642.3M |
| Number of holdings | 82 | 80 |
| Portfolio turnover | 59% | 41% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GTHRX | SWHFX | Difference |
|---|---|---|---|
| 2024 | +4.0% | +0.1% | +3.9% |
| 2023 | +3.1% | +0.7% | +2.4% |
| 2022 | −13.5% | −4.7% | −8.9% |
| 2021 | +12.2% | +23.3% | −11.1% |
| 2020 | +14.5% | +12.9% | +1.6% |
| 2019 | +32.0% | +17.6% | +14.4% |
| 2018 | +0.5% | +4.0% | −3.5% |
| 2017 | +15.5% | +20.2% | −4.7% |
| 2016 | −11.7% | −4.4% | −7.4% |
Source: Fund prospectus bar charts
Holdings overlap
8 of GTHRX's top 25 holdings also appear in SWHFX's top 25.
| Holding | GTHRX | SWHFX |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 13.92% |
| Johnson & Johnson | 6.76% | 6.94% |
| UnitedHealth Group Inc. | 6.17% | 4.74% |
| Merck & Co., Inc. | 4.59% | 4.98% |
| AbbVie Inc. | 4.03% | 5.81% |
| Gilead Sciences, Inc. | 3.63% | 3.24% |
| Vertex Pharmaceuticals Inc. | 2.01% | 1.89% |
| Thermo Fisher Scientific Inc. | 1.55% | 2.16% |
Source: SEC Form N-PORT
GTHRX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between GTHRX and SWHFX?
Which is cheaper, GTHRX or SWHFX?
Should I own both GTHRX and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.